Sriskandarajah, P., Pawlyn, C., Mohammed, K., Dearden, C. E., Davies, F. E., Morgan, G. J., Boyd, K. D., Kaiser, M. F. (2017) The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience. LEUKEMIA & LYMPHOMA, 58 (2). pp. 494-497. ISSN 1042-8194

Full text not available from this repository.

Item Type:	Letter
Authors (ICR Faculty only):	Morgan, Gareth and Davies, Faith
All Authors:	Sriskandarajah, P., Pawlyn, C., Mohammed, K., Dearden, C. E., Davies, F. E., Morgan, G. J., Boyd, K. D., Kaiser, M. F.
Additional Information:	ISI Document Delivery No.: ED1JH Times Cited: 0 Cited Reference Count: 14 Sriskandarajah, Priya Pawlyn, Charlotte Mohammed, Kabir Dearden, Claire E. Davies, Faith E. Morgan, Gareth J. Boyd, Kevin D. Kaiser, Martin F. 0 TAYLOR & FRANCIS LTD ABINGDON LEUKEMIA LYMPHOMA
Uncontrolled Keywords:	REFRACTORY MULTIPLE-MYELOMA LOW-DOSE DEXAMETHASONE SURVIVAL BORTEZOMIB TRIAL IMIDS
Research teams:	ICR divisions > Clinical Studies > Molecular Haematology (including Cytogenetics Group and Cell Markers) ICR divisions > Molecular Pathology > Molecular Haematology (including Cytogenetics Group and Cell Markers) Closed research groups > Myeloma Targeted Treatment
Depositing User:	Barry Jenkins
Date Deposited:	05 Jan 2017 12:05
Last Modified:	05 Jan 2017 12:05
URI:	http://publications.icr.ac.uk/id/eprint/15535

Actions (login required)

View Item